Literature DB >> 27109516

Tyrosinemia type I: Case series with response to treatment to NTBC.

Ira Shah1, Forum Shah2.   

Abstract

We present four children with tyrosinemia and their response to NTBC [2-[2-nitro-4-trifluoromethylbenzoyl]-1, 3-cyclohexanedione]. One child received NTBC for only 3 months after which he was diagnosed to have hepatocellular carcinoma and underwent a living-related liver transplantation. The child is doing well post-transplant. Remaining three children have been on NTBC for almost 3 years, have normal liver functions, undetectable urine succinylacetone, and no portal hypertension or renal tubular acidosis.

Entities:  

Keywords:  Children; NTBC; Tyrosinemia

Mesh：

Substances：

Year:  2016        PMID： 27109516     DOI： 10.1007/s12664-016-0650-3

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


  7 in total

1.  [Clinical follow up of Chilean patients with tyrosinemia type 1 treated with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-ciclohexanedione (NTBC)].

Authors:  Erna Raimann; Verónica Cornejo; Carolina Arias; Juan Francisco Cabello; Gabriela Castro; Eloina Fernández; Alicia de la Parra
Journal:  Rev Med Chil       Date:  2012-02       Impact factor: 0.553

2.  Neurological crisis in hereditary tyrosinaemia and complete reversal after liver transplantation.

Authors:  G Noble-Jamieson; N Jamieson; P Clayton; S Bailey; M Ryalls; N D Barnes
Journal:  Arch Dis Child       Date:  1994-06       Impact factor: 3.791

3.  Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh.

Authors:  L A Mieles; C O Esquivel; D H Van Thiel; B Koneru; L Makowka; A G Tzakis; T E Starzl
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

4.  Tyrosinemia: a report of three cases from India.

Authors:  Ira Shah
Journal:  Indian J Gastroenterol       Date:  2013-02-14

Review 5.  Hepatorenal tyrosinemia.

Authors:  Teruo Kitagawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

Review 6.  Recommendations for the management of tyrosinaemia type 1.

Authors:  Corinne de Laet; Carlo Dionisi-Vici; James V Leonard; Patrick McKiernan; Grant Mitchell; Lidia Monti; Hélène Ogier de Baulny; Guillem Pintos-Morell; Ute Spiekerkötter
Journal:  Orphanet J Rare Dis       Date:  2013-01-11       Impact factor: 4.123

7.  Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.

Authors:  Sebene Mayorandan; Uta Meyer; Gülden Gokcay; Nuria Garcia Segarra; Hélène Ogier de Baulny; Francjan van Spronsen; Jiri Zeman; Corinne de Laet; Ute Spiekerkoetter; Eva Thimm; Arianna Maiorana; Carlo Dionisi-Vici; Dorothea Moeslinger; Michaela Brunner-Krainz; Amelie Sophia Lotz-Havla; José Angel Cocho de Juan; Maria Luz Couce Pico; René Santer; Sabine Scholl-Bürgi; Hanna Mandel; Yngve Thomas Bliksrud; Peter Freisinger; Luis Jose Aldamiz-Echevarria; Michel Hochuli; Matthias Gautschi; Jessica Endig; Jens Jordan; Patrick McKiernan; Stefanie Ernst; Susanne Morlot; Arndt Vogel; Johannes Sander; Anibh Martin Das
Journal:  Orphanet J Rare Dis       Date:  2014-08-01       Impact factor: 4.123
  7 in total
  1 in total

Review 1.  Liver Transplantation for Pediatric Hepatocellular Carcinoma: A Systematic Review.

Authors:  Christos D Kakos; Ioannis A Ziogas; Charikleia D Demiri; Stepan M Esagian; Konstantinos P Economopoulos; Dimitrios Moris; Georgios Tsoulfas; Sophoclis P Alexopoulos
Journal:  Cancers (Basel)       Date:  2022-03-02       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.